WuXi Biologics to sell Irish vaccine site to Merck for $500M

WuXi Biologics’ subsidiary WuXi Vaccines is divesting a manufacturing facility in Dundalk, Ireland, to Merck for $500 million, roughly a week after WuXi AppTec also announced it's shrinking its footprint. WuXi Vaccines expects to close ...